Solutions and Services | Pharmaco-Vigilance & Safety

Periodic Reporting (PSURs, DSURs, Addendum to Clinical Overview)

Contact us now to receive further information and an assessment from our experts. We will work with you to evaluate the best approach for your business processes.

Periodic Reporting, encompassing Periodic Safety Update Reports (PSURs), Development Safety Update Reports (DSURs), and Addendum to Clinical Overview, is a regulatory requirement that plays a pivotal role in the ongoing assessment of a medicinal product’s risk-benefit balance.

These reports are critical for marketing authorisation holders, as they provide regulatory authorities with an update on the global safety information of a product, reflecting any new risks or changes in the known risk profile.

The preparation and maintenance of these documents are essential during both the clinical development and post-authorisation phases, ensuring that all safety information is accurately captured and analysed.

At Arithmos, we offer comprehensive services in the preparation of pharmacovigilance documents, meticulously aligned with EU legal requirements.

Our expertise includes:

 

  • PSURs: Crafting detailed reports that evaluate the risk-benefit balance of a medicinal product, considering new safety information and its impact on the product’s overall profile.

 

  • DSURs: Providing annual updates on the safety of drugs under clinical investigation, highlighting any significant findings from ongoing or completed studies.

 

  • Addendum to Clinical Overview: Summarising the safety profile of a product, particularly for renewal applications, to reflect the current understanding of the risk-benefit balance.

 

Our team ensures that your periodic reports are not only compliant with the latest regulations but also provide a comprehensive analysis that supports the safe and effective use of your medicinal products.

With Arithmos, you can confidently navigate the complexities of periodic reporting, secure in the knowledge that your submissions will contribute to the protection of public health.

Get an assessment

Let’s work together to address the challenges in pharmacovigilance and ensure the safety of patients worldwide. Contact us to explore how our services can solve your pharmacovigilance needs.